Table 3.

Compliance to bisphosphonate treatments over 12 months

MPR	Monthly ibandronate (N = 1,001)	Weekly bisphosphonates (N = 1,989)	p value
Mean±SD (95% CI)	84.5 ± 23.0 (83.1–85.9)	79.4 ± 26.7 (78.2–80.5)	<0.001
Adjusteda mean±SD (95%CI)	84.5 ± 25.9 (82.9–86.2)	79.3 ± 25.7 (78.2–80.4)	<0.001
<20%	20 (2.0%)	98 (4.9%)	<0.001
20–<40%	61 (6.1%)	169 (8.5%)
40–<60%	85 (8.5%)	179 (9.0%)
60–<80%	93 (9.3%)	234 (11.8%)
≥80%	742 (74.1%)	1,309 (65.8%)

MPR medication possession ratio

^aGeneral linear model adjusted by propensity score